查看購物車
  • Simplified Chinese
  • English
2031年北美醫療外骨骼市場預測—區域分析—按組件、類型、肢體、應用、移動性和最終用戶
市場調查報告書
商品編碼
1715171

2031年北美醫療外骨骼市場預測—區域分析—按組件、類型、肢體、應用、移動性和最終用戶

North America Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users
出版日期: | 出版商: The Insight Partners | 英文 102 Pages | 訂單完成後即時交付

價格

2023年北美醫療外骨骼市場價值為1.593億美元，預計到2031年將達到14.0025億美元；預計2023年至2031年的複合年成長率為31.2%。

策略性措施不斷增加推動北美醫療外骨市場發展

在醫療外骨骼市場營運的大小公司採用各種策略來提高收入，例如地理擴張、新產品發布和技術進步。以下提到了醫療外骨骼市場的一些最新發展； 2022 年 7 月，Ekso Bionics Holdings Inc. 獲得美國食品藥物管理局 (FDA) 的批准，向多發性硬化症患者銷售其 EksoNR 機器人外骨骼。它於 2016 年獲批用於中風和脊髓損傷 (SCI) 康復，並於 2020 年獲得腦損傷復健治療許可。它還獲得了 CE 認證，並在歐洲上市。

三星電子的輔助機器人「GEMS Hip」獲得了美國 FDA 的認證，這是一款穿戴式設備，可作為行動不便用戶的外骨骼，使用主動輔助演算法來改善步態和肌肉運動。 2021年12月，德國Bionic公司推出第五代Cray X外骨骼。第五代 Cray X 彰顯了其在快速成長的國際外骨骼市場的技術領先地位。該公司的創新正在為全球更多個人和企業在更廣泛的用例和行業中受益鋪平道路。 2021 年 11 月，奧托博克收購了位於灣區的外骨骼新創公司 SuitX。 SuitX 是加州大學柏克萊分校機器人與人類工程實驗室的衍生公司。兩家公司實際上都屬於同一類別，生產用於兩個不同目的（工作輔助和醫療保健）的機器人外骨骼。 2021年5月，Roam Robotics推出了智慧膝關節矯正器“Ascend”，可幫助穿戴者減輕膝關節疼痛並恢復活動能力。它能感知身體的運動，根據配戴者的需求自動調整，並在適當的時刻為目標肌肉群提供精確的支撐。它是經過 FDA 批准的註冊 I 類設備，可直接購買或透過私人和醫療保險購買，從根本上擴大了公眾對穿戴式機器人設備的可及性。因此，市場參與者積極參與產品發布、擴張、合作和併購，推動了醫療外骨骼市場的成長。

北美醫療外骨骼市場概況

市場參與者正在獲得美國的產品批准，以增強外骨骼業務。例如，2022 年 7 月，Ekso Bionics Holdings Inc. 獲得美國食品藥物管理局 (FDA) 的行銷批准，其 EksoNR 機器人外骨骼可用於治療多發性硬化症患者。因此，美國醫療保健產業各醫療器材巨頭的不斷發展將在未來幾年進一步推動該國醫療外骨骼市場的發展。

北美醫療外骨骼市場收入及預測（2031年）（百萬美元）

北美醫療外骨市場細分

北美醫療外骨骼市場分為組件、類型、肢體、應用、移動性、最終用戶和國家。

根據組成部分，北美醫療外骨骼市場分為硬體和軟體。 2023 年，硬體部分佔據了北美醫療外骨骼市場的較大佔有率。

從類型來看，北美醫療外骨骼市場分為動力外骨骼和被動外骨骼。 2023 年，動力外骨骼領域佔據了北美醫療外骨骼市場的較大佔有率。

根據肢體，北美醫療外骨骼市場分為下半身外骨骼、上半身外骨骼和全身外骨骼。 2023 年，下肢外骨骼領域佔據北美醫療外骨骼市場的最大佔有率。

根據應用，北美醫療外骨骼市場分為脊髓損傷、多發性硬化症、中風、腦性麻痺、巴金森氏症等。 2023 年，脊髓損傷領域佔據北美醫療外骨骼市場的最大佔有率。

就移動性而言，北美醫療外骨骼市場分為移動外骨骼和固定外骨骼。 2023 年，動力外骨骼領域佔據了北美醫療外骨骼市場的較大佔有率。

根據最終用戶，北美醫療外骨骼市場分為復健中心、物理治療中心、長期照護中心、家庭護理機構等。 2023 年，復健中心部門佔據北美醫療外骨骼市場的最大佔有率。

根據國家/地區，北美醫療外骨骼市場分為美國、加拿大和墨西哥。 2023 年，美國佔據北美醫療外骨骼市場的最大佔有率。

比奧尼克； B-Temia 公司； Cyber​​dyne公司； Ekso Bionics Holdings Inc； ExoAtlet；霍科馬股份公司； Lifeward 公司； Myomo 公司；和 Rex Bionics Ltd. 是北美醫療外骨骼市場的一些領先公司。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：北美醫療外骨骼市場-關鍵市場動態

  • 市場促進因素：
    • 策略舉措不斷增加
    • 中風和肌肉骨骼疾病發生率不斷上升
    • 老年人口壽命延長
  • 市場限制
    • 產品成本高和監管問題
  • 市場機會
    • 脊髓損傷盛行率不斷上升
  • 未來趨勢
    • 科技進步不斷加快，投資不斷增加
  • 促進因素和限制因素的影響：

第5章：醫療外骨骼市場-北美分析

  • 2021-2031年北美醫療外骨骼市場收入
  • 北美醫療外骨骼市場預測分析

第6章：北美醫療外骨骼市場分析-按組件

  • 硬體
  • 軟體

第7章：北美醫療外骨骼市場分析-按類型

  • 動力外骨骼
  • 被動外骨骼

第 8 章：北美醫療外骨骼市場分析 - Extremity

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第9章：北美醫療外骨骼市場分析-按應用

  • 脊髓損傷
  • 多發性硬化症
  • 中風
  • 腦性麻痺
  • 帕金森氏症
  • 其他

第 10 章：北美醫療外骨骼市場分析 - 按移動性

  • 移動外骨骼
  • 固定式外骨骼

第 11 章：北美醫療外骨骼市場分析 - 按最終用戶

  • 復健中心
  • 物理治療中心
  • 長期照護中心
  • 家庭護理設置
  • 其他

第 12 章：北美醫療外骨骼市場-國家分析

  • 美國
  • 加拿大
  • 墨西哥

第 13 章：醫療外骨骼市場-產業格局

  • 概述
  • 醫療外骨骼市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Myomo Inc
  • Rex Bionics Ltd.

第 15 章：附錄

Product Code: BMIRE00031137

The North America medical exoskeleton market was valued at US$ 159.30 million in 2023 and is expected to reach US$ 1,400.25 million by 2031; it is estimated to register a CAGR of 31.2% from 2023 to 2031.

Rising Number of Strategic Initiatives Fuels North America Medical Exoskeleton Market

Small and big companies operating in the medical exoskeleton market adopt various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the medical exoskeleton market are mentioned below; In July 2022, Ekso Bionics Holdings Inc. received approval from the US Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for patients suffering from multiple sclerosis. It was cleared for stroke and spinal cord injury (SCI) rehabilitation in 2016 and acquired brain injury in 2020. It has also received CE certification and is available in Europe.

Samsung Electronics has received the US FDA for its assistive robot "GEMS Hip," a wearable device that acts as an exoskeleton for users with mobility issues using an active assist algorithm to improve gait and muscle movement. In December 2021, German Bionic launched the fifth generation of the Cray X exoskeleton. The fifth-generation Cray X underscores technology leadership in the massively growing international exoskeleton market. The company's innovations are paving the way for more people and businesses worldwide to benefit across a wider range of use cases and industries. In November 2021, Ottobock acquired Bay Area-based exoskeleton startup SuitX. SuitX is a spinout of UC Berkeley's Robotics and Human Engineering Lab. Both companies effectively operate in the same category, producing robotic exoskeletons designed for two distinct purposes-work assistance and healthcare. In May 2021, Roam Robotics launched "Ascend," a smart knee orthosis that helps wearers reduce knee pain and regain mobility. It senses the body's movement, automatically adjusts to the wearer's needs, and provides precise support at the right moment for target muscle groups. It is a registered Class I device with FDA approval available for purchase directly and through private and Medicare insurance, radically expanding public accessibility to wearable robotic devices. Therefore, the active participation of market players in product launches, expansions, partnerships, and mergers & acquisitions boosts the growth of the medical exoskeleton market.

North America Medical Exoskeleton Market Overview

Market players are receiving product approvals in the US to enhance the exoskeleton business. For instance, in July 2022, Ekso Bionics Holdings Inc. received marketing approval from the US Food and Drug Administration for its EksoNR robotic exoskeleton to use in patients with multiple sclerosis. Thus, the growing developments by various medical device giants in the US healthcare industry will further boost the market for medical exoskeletons in the country in the upcoming years.

North America Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

North America Medical Exoskeleton Market Segmentation

The North America medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the North America medical exoskeleton market is segmented into hardware and software. The hardware segment held a larger share of the North America medical exoskeleton market share in 2023.

In terms of type, the North America medical exoskeleton market is segmented into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the North America medical exoskeleton market share in 2023.

Based on extremity, the North America medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the North America medical exoskeleton market share in 2023.

By application, the North America medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the North America medical exoskeleton market share in 2023.

In terms of mobility, the North America medical exoskeleton market is segmented into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the North America medical exoskeleton market share in 2023.

By end users, the North America medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the North America medical exoskeleton market share in 2023.

Based on country, the North America medical exoskeleton market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the North America medical exoskeleton market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Medical Exoskeleton Market - Key Market Dynamics

  • 4.1 Market Drivers:
    • 4.1.1 Rising Number of Strategic Initiatives
    • 4.1.2 Growing Incidence of Stroke and Musculoskeletal
    • 4.1.3 Increasing Longevity of Aging Population
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Product and Regulatory Concerns
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Prevalence of SCI
  • 4.4 Future Trends
    • 4.4.1 Increasing Technological Advancements and Rising Investments
  • 4.5 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - North America Analysis

  • 5.1 North America Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Medical Exoskeleton Market Forecast Analysis

6. North America Medical Exoskeleton Market Analysis - by Component

  • 6.1 Hardware
    • 6.1.1 Overview
    • 6.1.2 Hardware: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Software: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Medical Exoskeleton Market Analysis - by Type

  • 7.1 Powered Exoskeleton
    • 7.1.1 Overview
    • 7.1.2 Powered Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Passive Exoskeleton
    • 7.2.1 Overview
    • 7.2.2 Passive Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Medical Exoskeleton Market Analysis - by Extremity

  • 8.1 Lower Body Exoskeleton
    • 8.1.1 Overview
    • 8.1.2 Lower Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Body Exoskeleton
    • 8.2.1 Overview
    • 8.2.2 Upper Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Full Body Exoskeleton
    • 8.3.1 Overview
    • 8.3.2 Full Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Medical Exoskeleton Market Analysis - by Application

  • 9.1 Spinal Cord Injury
    • 9.1.1 Overview
    • 9.1.2 Spinal Cord Injury: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Multiple Sclerosis
    • 9.2.1 Overview
    • 9.2.2 Multiple Sclerosis: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Stroke
    • 9.3.1 Overview
    • 9.3.2 Stroke: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cerebral Palsy
    • 9.4.1 Overview
    • 9.4.2 Cerebral Palsy: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Parkinson's Diseases
    • 9.5.1 Overview
    • 9.5.2 Parkinson's Diseases: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Medical Exoskeleton Market Analysis - by Mobility

  • 10.1 Mobile Exoskeleton
    • 10.1.1 Overview
    • 10.1.2 Mobile Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Stationary Exoskeleton
    • 10.2.1 Overview
    • 10.2.2 Stationary Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Medical Exoskeleton Market Analysis - by End Users

  • 11.1 Rehabilitation Centers
    • 11.1.1 Overview
    • 11.1.2 Rehabilitation Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Physiotherapy Centers
    • 11.2.1 Overview
    • 11.2.2 Physiotherapy Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Long Term Care Centers
    • 11.3.1 Overview
    • 11.3.2 Long Term Care Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Homecare Settings
    • 11.4.1 Overview
    • 11.4.2 Homecare Settings: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Medical Exoskeleton Market - Country Analysis

  • 12.1 North America Medical Exoskeleton Market
    • 12.1.1 North America Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.1.1.1.1 United States: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.1.2 United States: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.1.3 United States: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.1.4 United States: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.1.5 United States: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.1.6 United States: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.2 Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Canada: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.2.1.1 Canada: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.2.1.1.1 Canada: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.2.2 Canada: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.2.3 Canada: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.2.4 Canada: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.2.5 Canada: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.2.6 Canada: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.3 Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Mexico: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.3.1.1 Mexico: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.3.1.1.1 Mexico: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.3.2 Mexico: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.3.3 Mexico: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.3.4 Mexico: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.3.5 Mexico: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.3.6 Mexico: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Medical Exoskeleton Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Ekso Bionics Holdings Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lifeward, Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ExoAtlet
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cyberdyne Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 BIONIK
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B-Temia Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hocoma AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Myomo Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Rex Bionics Ltd.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Medical Exoskeleton Market Segmentation
  • Table 2. North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. North America Medical Exoskeleton Market, by Hardware - Revenue and Forecast to 2031 (USD Million)
  • Table 4. North America Medical Exoskeleton Market, by Actuators - Revenue and Forecast to 2031 (USD Million)
  • Table 5. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 6. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 7. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 8. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 10. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 12. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 13. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 14. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 15. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 16. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 17. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 18. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 19. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 20. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 21. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Component
  • Table 22. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Hardware
  • Table 23. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Actuators
  • Table 24. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 25. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Extremity
  • Table 26. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 27. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by Mobility
  • Table 28. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million) - by End Users
  • Table 29. Recent Organic Growth Strategies in Medical Exoskeleton Market
  • Table 30. Recent Inorganic Growth Strategies in the Medical Exoskeleton Market
  • Table 31. Glossary of Terms, Medical Exoskeleton Market

List Of Figures

  • Figure 1. North America Medical Exoskeleton Market Segmentation, by Country
  • Figure 2. North America Medical Exoskeleton Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Medical Exoskeleton Market Share (%) - by Component (2023 and 2031)
  • Figure 6. Hardware: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Software: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. North America Medical Exoskeleton Market Share (%) - by Type (2023 and 2031)
  • Figure 9. Powered Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Passive Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. North America Medical Exoskeleton Market Share (%) - by Extremity (2023 and 2031)
  • Figure 12. Lower Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Upper Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Full Body Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. North America Medical Exoskeleton Market Share (%) - by Application (2023 and 2031)
  • Figure 16. Spinal Cord Injury: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Multiple Sclerosis: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Stroke: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Cerebral Palsy: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Parkinson's Diseases: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. North America Medical Exoskeleton Market Share (%) - by Mobility (2023 and 2031)
  • Figure 23. Mobile Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Stationary Exoskeleton: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. North America Medical Exoskeleton Market Share (%) - by End Users (2023 and 2031)
  • Figure 26. Rehabilitation Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Physiotherapy Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Long Term Care Centers: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Homecare Settings: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Others: North America Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. North America Medical Exoskeleton Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 32. North America Medical Exoskeleton Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. United States: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Canada: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 35. Mexico: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Growth Strategies in Medical Exoskeleton Market